

Driving Automated Workflows & Accelerating Drug Development with AI-Powered Trials - with Michelle Longmire of Medable
Jan 29, 2025
In this discussion, Michelle Longmire, Co-founder and CEO of Medable, shares her insights on how AI is revolutionizing clinical trials. She explains how AI enhances patient experiences and streamlines processes for sponsors. Michelle dives into the importance of real-time data analysis and smarter recruitment strategies in drug development. She also addresses the challenges of integrating AI within existing frameworks and the need for organizations to balance speed with regulatory compliance. This conversation offers a forward-thinking perspective on the future of clinical research.
Chapters
Transcript
Episode notes
1 2 3 4 5
Intro
00:00 • 3min
Enhancing Drug Development Through Real-Time Data Analysis
02:55 • 3min
Harnessing AI for Predictive Analytics in Clinical Trials and Manufacturing
06:12 • 3min
AI Revolutionizing Clinical Trials
09:00 • 11min
Transforming Clinical Trials: The Impact of AI on Efficiency and Decision-Making
20:19 • 2min